Table 1 Demographic, clinical and biochemical characteristics of study subjects
From: Knockdown of NCK1-AS1 inhibits the development of atherosclerosis by targeting miR-1197/COX10 axis
Healthy | AS | |
|---|---|---|
Age (years) | 51.5 + 8.5 | 53.7 + 9.5 |
Male/Female (n/n) | 16/16 | 18/14 |
Total cholesterol (mmol/L) | 4.45 + 0.5 | 4.8 + 1.35 |
Low density lipoprotein (mmol/L) | 2.6 + 0.35 | 3.1 + 1.10 |
High density lipoprotein (mmol/L) | 1.31 + 0.15 | 1 + 0.32 |
Total triglyceride (mmol/L) | 0.98 + 0.35 | 1.6 + 0.88 |
Diabetes mellitus (n) | 5 | 18 |
Serum creatine (mmol/L) | 45.6 + 12.4 | 48.9 + 9.5 |
MDRD (ml/min per1.75 m^2) | 87.5 + 5 | 90.25 + 7.8 |
NT-proBNP (pg/ml) | 53.5 + 15.4 | 60.6 + 10.5 |
Aspirin (n) | 2 | 10 |
Statins (n) | 0 | 24 |